Kamal Jagat Singh
About Kamal Jagat Singh
Data last updated:
Kamal Jagat Singh is a Director at Abriva Life Science Private Limited (since 2020). The company operates in Trading. Abriva Life Science Private Limited reported revenue of ₹62.8 Lakh (FY 2024).
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
 Abriva Life Science Private Limited U51909MH2020PTC340973 | Director | 24 Jun 2020 | 2020 | ₹62.8 Lakh (FY 2024) | Active |
Board colleagues of Kamal Jagat Singh
| Name | DIN | Company | Designation |
|---|---|---|---|
| Ashish Gupta | 00514797 | Abriva Life Science Private Limited | Director |
| Dev Sarop Chand | 08602510 | Abriva Life Science Private Limited | Director |
| Ram Gopal Mandowara | 07561891 | Abriva Life Science Private Limited | Director |
| Sunil Ramakant Nakhawa | 02861093 | Abriva Life Science Private Limited | Director |
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Kamal Jagat Singh
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Kamal Jagat Singh
Kamal Jagat Singh currently holds 1 directorship: Abriva Life Science Private Limited (Director, since 24 Jun 2020, revenue ₹62.8 Lakh (FY 2024)).
Kamal Jagat Singh was first appointed on 24 Jun 2020 as Director at Abriva Life Science Private Limited.
The current boards of Kamal Jagat Singh's companies include Ashish Gupta (Abriva Life Science Private Limited), Dev Sarop Chand (Abriva Life Science Private Limited), Ram Gopal Mandowara (Abriva Life Science Private Limited), Sunil Ramakant Nakhawa (Abriva Life Science Private Limited).